Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Sunovion Swallows Up Cynapsus in $624 Million Deal

Fresh off its filing for a new COPD drug, Massachusetts-based Sunovion Pharmaceuticals struck a $642 million deal to acquire Toronto-based Cynapsus Therapeutics and its Parkinson’s disease drug candidate.

Read More »

U.S. FDA strengthens warning over opioid/sedative combination

The U.S. Food and Drug Administration strengthened warnings about the danger of combining opioid painkillers or cough medicines containing opioids with benzodiazepines, a common class of sedatives.

Read More »

Novartis to Dissolve Cell and Gene Therapy Unit

Novartis AG is dissolving its Cell and Gene Therapy Unit, according to Endpoints News, citing a note sent to 400 employees by division president Usman Azam.

Read More »

More Trouble for Theranos as FDA Discovers Company Cut Corners With Zika Test

Embattled Theranos has run into another testing snag, this time with its proposed blood test for the Zika virus. The company was forced to withdraw its request for emergency clearance of the test after inspectors with the U.S. Food and Drug Administration found the company did not include proper patient protections in its study, according to the Wall Street Journal.

Read More »

Stock Pops as Medivir Decides to Split into Two Companies

Medivir AB announced that it plans to split up into two independent companies.

Read More »

Express Scripts diabetes program aims to cap costs for customers

Express Scripts Holding, the largest U.S. pharmacy benefit manager, said it will implement a program in 2017 that guarantees per-patient spending caps on diabetes drug costs in an effort to limit soaring increases for its customers.

Read More »

Study finds flaws in criticism of St. Jude cyber security

University of Michigan researchers said their own experiments undermine recent allegations of security flaws in St. Jude Medical Inc.’s pacemakers and other implantable medical devices.

Read More »

FDA approves Novartis biosimilar to Amgen’s Enbrel

The U.S. Food and Drug Administration approved Novartis AG’s biosimilar version of Amgen Inc.’s arthritis drug Enbrel.

Read More »

PBMs’ Attack on Physician Dispensing and Impact on Patient Care

A White Paper from the Community Oncology Alliance (COA) looks at recent moves by Pharmacy Benefit Managers (PBMs) to increase corporate profits by declaring all physician dispensing to be out-of-network.

Read More »

Want to detect gluten on the go? There’s a device for that

A California startup has developed a portable technology that will allow consumers to test their food for gluten on the go.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!


Ad Right Bottom